Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Aquaporin-4 facilitator TGN-073 promotes interstitial fluid circulation within the blood-brain barrier: [17O]H2O JJVCPE MRI study.

Huber VJ, Igarashi H, Ueki S, Kwee IL, Nakada T.

Neuroreport. 2018 Mar 20. doi: 10.1097/WNR.0000000000000990. [Epub ahead of print]

PMID:
29481527
2.

Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.

Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan.

PMID:
29371382
3.

MIAQuant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices.

Casiraghi E, Cossa M, Huber V, Rivoltini L, Tozzi M, Villa A, Vergani B.

Eur J Histochem. 2017 Nov 2;61(4):2838. doi: 10.4081/ejh.2017.2838.

4.

Projections of temperature-related excess mortality under climate change scenarios.

Gasparrini A, Guo Y, Sera F, Vicedo-Cabrera AM, Huber V, Tong S, de Sousa Zanotti Stagliorio Coelho M, Nascimento Saldiva PH, Lavigne E, Matus Correa P, Valdes Ortega N, Kan H, Osorio S, Kyselý J, Urban A, Jaakkola JJK, Ryti NRI, Pascal M, Goodman PG, Zeka A, Michelozzi P, Scortichini M, Hashizume M, Honda Y, Hurtado-Diaz M, Cesar Cruz J, Seposo X, Kim H, Tobias A, Iñiguez C, Forsberg B, Åström DO, Ragettli MS, Guo YL, Wu CF, Zanobetti A, Schwartz J, Bell ML, Dang TN, Van DD, Heaviside C, Vardoulakis S, Hajat S, Haines A, Armstrong B.

Lancet Planet Health. 2017 Dec;1(9):e360-e367. doi: 10.1016/S2542-5196(17)30156-0.

5.

The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Smith AM, Huber VC.

Viral Immunol. 2018 Mar;31(2):159-173. doi: 10.1089/vim.2017.0138. Epub 2017 Nov 17.

PMID:
29148920
6.

Binding host proteins to the M protein contributes to the mortality associated with influenza-Streptococcus pyogenes superinfections.

Herrera AL, Suso K, Allison S, Simon A, Schlenker E, Huber VC, Chaussee MS.

Microbiology. 2017 Sep 25. doi: 10.1099/mic.0.000532. [Epub ahead of print]

7.

So You Want To Be A Reviewer.

Vogt HB, Huber VC, Hansen KA.

S D Med. 2017 Mar;70(3):127-133.

PMID:
28813775
8.

Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma.

Suzuki Y, Nakamura Y, Yamada K, Kurabe S, Okamoto K, Aoki H, Kitaura H, Kakita A, Fujii Y, Huber VJ, Igarashi H, Kwee IL, Nakada T.

Neurosurgery. 2017 Jun 21. doi: 10.1093/neuros/nyx314. [Epub ahead of print]

PMID:
28645205
9.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L.

Semin Cancer Biol. 2017 Apr;43:74-89. doi: 10.1016/j.semcancer.2017.03.001. Epub 2017 Mar 6. Review.

10.

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Vallacchi V, Camisaschi C, Dugo M, Vergani E, Deho P, Gualeni A, Huber V, Gloghini A, Maurichi A, Santinami M, Sensi M, Castelli C, Rivoltini L, Rodolfo M.

Genes (Basel). 2016 Dec 14;7(12). pii: E124.

11.

Publisher's Note: "In-vessel calibration of the imaging diagnostics for the real-time protection of the JET ITER-like wall" [Rev. Sci. Instrum. 87, 11D430 (2016)].

Huber V, Huber A, Kinna D, Balboa I, Collins S, Conway N, Drewelow P, Maggi CF, Matthews GF, Meigs AG, Mertens P, Price M, Sergienko G, Silburn S, Wynn A, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11F903. No abstract available.

PMID:
27910683
12.

Recent developments of in-vessel calibration of mid-IR cameras at JET.

Balboa I, Silburn S, Drewelow P, Huber V, Huber A, Kinna D, Price M, Matthews GF, Collins S, Fessey J, Rack M, Trimble P, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11D419.

PMID:
27910440
13.

In-vessel calibration of the imaging diagnostics for the real-time protection of the JET ITER-like wall.

Huber V, Huber A, Kinna D, Balboa I, Collins S, Conway N, Drewelow P, Maggi CF, Matthews GF, Meigs AG, Mertens P, Price M, Sergienko G, Silburn S, Wynn A, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11D430.

PMID:
27910322
14.

Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.

Wang Z, Kedzierski L, Nuessing S, Chua BY, Quiñones-Parra SM, Huber VC, Jackson DC, Thomas PG, Kedzierska K.

J Gen Virol. 2016 Dec;97(12):3205-3214. doi: 10.1099/jgv.0.000651. Epub 2016 Nov 2.

PMID:
27902386
15.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2016 Nov 15;14(1):313.

16.

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.

Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V.

Vaccines (Basel). 2016 Nov 4;4(4). pii: E38. Review.

17.

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.

Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, Locati L, Alfieri S, Imbimbo M, Granata R, Mariani L, Iacovelli NA, Huber V, Cavallo A, Licitra L, Rivoltini L.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.

PMID:
27745982
19.

Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.

Shepardson KM, Larson K, Morton RV, Prigge JR, Schmidt EE, Huber VC, Rynda-Apple A.

MBio. 2016 May 3;7(3). pii: e00506-16. doi: 10.1128/mBio.00506-16.

21.

The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Herrera AL, Huber VC, Chaussee MS.

Front Microbiol. 2016 Mar 21;7:342. doi: 10.3389/fmicb.2016.00342. eCollection 2016. Review.

22.

TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.

Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, Bürdek M, Botti L, Arioli I, Cova A, Mauri G, Vergani E, Bianchi B, Della Mina P, Cantone L, Bollati V, Zaffaroni N, Gianni AM, Colombo MP, Huber V.

Clin Cancer Res. 2016 Jul 15;22(14):3499-512. doi: 10.1158/1078-0432.CCR-15-2170. Epub 2016 Mar 4.

23.

Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.

McCormick K, Jiang Z, Zhu L, Lawson SR, Langenhorst R, Ransburgh R, Brunick C, Tracy MC, Hurtig HR, Mabee LM, Mingo M, Li Y, Webby RJ, Huber VC, Fang Y.

PLoS One. 2015 Jun 10;10(6):e0127649. doi: 10.1371/journal.pone.0127649. eCollection 2015.

24.

N-acetylaspartate decrease in acute stage of ischemic stroke: a perspective from experimental and clinical studies.

Igarashi H, Suzuki Y, Huber VJ, Ida M, Nakada T.

Magn Reson Med Sci. 2015;14(1):13-24. doi: 10.2463/mrms.2014-0039. Epub 2014 Dec 15. Review.

25.

Ligand-based molecular MRI: O-17 JJVCPE amyloid imaging in transgenic mice.

Suzuki K, Igarashi H, Huber VJ, Kitaura H, Kwee IL, Nakada T.

J Neuroimaging. 2014 Nov-Dec;24(6):595-598. doi: 10.1111/jon.12091. Epub 2014 Feb 23.

26.

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.

Tazzari M, Negri T, Rini F, Vergani B, Huber V, Villa A, Dagrada P, Colombo C, Fiore M, Gronchi A, Stacchiotti S, Casali PG, Pilotti S, Rivoltini L, Castelli C.

Br J Cancer. 2014 Sep 23;111(7):1350-62. doi: 10.1038/bjc.2014.437. Epub 2014 Aug 7.

27.

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Klonoski JM, Hurtig HR, Juber BA, Schuneman MJ, Bickett TE, Svendsen JM, Burum B, Penfound TA, Sereda G, Dale JB, Chaussee MS, Huber VC.

Vaccine. 2014 Sep 8;32(40):5241-9. doi: 10.1016/j.vaccine.2014.06.093. Epub 2014 Jul 29.

28.

Enhanced response to pulmonary Streptococcus pneumoniae infection is associated with primary ciliary dyskinesia in mice lacking Pcdp1 and Spef2.

McKenzie CW, Klonoski JM, Maier T, Trujillo G, Vitiello PF, Huber VC, Lee L.

Cilia. 2013 Dec 20;2(1):18. doi: 10.1186/2046-2530-2-18.

29.

The Inter-Sectoral Impact Model Intercomparison Project (ISI-MIP): project framework.

Warszawski L, Frieler K, Huber V, Piontek F, Serdeczny O, Schewe J.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3228-32. doi: 10.1073/pnas.1312330110. Epub 2013 Dec 16.

30.

Influenza vaccines: from whole virus preparations to recombinant protein technology.

Huber VC.

Expert Rev Vaccines. 2014 Jan;13(1):31-42. doi: 10.1586/14760584.2014.852476. Review.

PMID:
24192014
31.

Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit.

Pradier A, Tabone-Eglinger S, Huber V, Bosshard C, Rigal E, Wehrle-Haller B, Roosnek E.

Eur J Immunol. 2014 Feb;44(2):511-20. doi: 10.1002/eji.201343868. Epub 2013 Nov 20.

32.

Alloying and Structure of Ultrathin Gallium Films on the (111) and (110) Surfaces of Palladium.

Stadlmayr W, Huber V, Penner S, Klötzer B, Memmel N.

J Phys Chem C Nanomater Interfaces. 2013 Sep 26;117(38):19558-19567. Epub 2013 Sep 2.

33.

Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes.

Stradner MH, Gruber G, Angerer H, Huber V, Setznagl D, Kremser ML, Moazedi-Fürst FC, Windhager R, Graninger WB.

Arthritis Rheum. 2013 Aug;65(8):2113-22. doi: 10.1002/art.37989.

34.

Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant.

Sun Z, Lawson S, Langenhorst R, McCormick KL, Brunick C, Opriessnig T, Baker R, Yoon KJ, Zhang W, Huber VC, Fang Y.

Vet Microbiol. 2013 Jun 28;164(3-4):229-38. doi: 10.1016/j.vetmic.2013.02.010. Epub 2013 Feb 26.

PMID:
23497910
35.

Can surveillance of the influenza virus PB1-F2 gene be used to predict the severity of secondary bacterial infections?

Huber VC.

Virulence. 2012 Oct 1;3(6):523-4. doi: 10.4161/viru.21811. Epub 2012 Oct 1. No abstract available.

36.

Immune surveillance properties of human NK cell-derived exosomes.

Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A, Podo F, Rivoltini L, Ramoni C, Fais S.

J Immunol. 2012 Sep 15;189(6):2833-42. doi: 10.4049/jimmunol.1101988. Epub 2012 Aug 17.

37.

Aquaporin-4 positron emission tomography imaging of the human brain: first report.

Suzuki Y, Nakamura Y, Yamada K, Huber VJ, Tsujita M, Nakada T.

J Neuroimaging. 2013 Apr;23(2):219-23. doi: 10.1111/j.1552-6569.2012.00704.x. Epub 2012 Jul 20.

PMID:
22817997
38.

Characterization of a porcine intestinal epithelial cell line for influenza virus production.

Sun Z, Huber VC, McCormick K, Kaushik RS, Boon AC, Zhu L, Hause B, Webby RJ, Fang Y.

J Gen Virol. 2012 Sep;93(Pt 9):2008-16. doi: 10.1099/vir.0.044388-0. Epub 2012 Jun 27.

39.

Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens.

Weeks-Gorospe JN, Hurtig HR, Iverson AR, Schuneman MJ, Webby RJ, McCullers JA, Huber VC.

J Virol. 2012 Sep;86(17):9035-43. doi: 10.1128/JVI.00369-12. Epub 2012 Jun 6.

40.

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, Cova A, Canese R, Jachetti E, Rossetti M, Huber V, Parmiani G, Generoso L, Santinami M, Borghi M, Fais S, Bellone M, Rivoltini L.

Cancer Res. 2012 Jun 1;72(11):2746-56. doi: 10.1158/0008-5472.CAN-11-1272. Epub 2012 May 16.

41.

Brain water channel proteins in health and disease.

Benga O, Huber VJ.

Mol Aspects Med. 2012 Oct-Dec;33(5-6):562-78. doi: 10.1016/j.mam.2012.03.008. Epub 2012 Apr 7. Review.

PMID:
22504060
42.

Recent advances on the role of tumor exosomes in immunosuppression and disease progression.

Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V.

Semin Cancer Biol. 2012 Aug;22(4):342-9. doi: 10.1016/j.semcancer.2012.02.005. Epub 2012 Feb 19. Review.

43.

Aquaporins in drug discovery and pharmacotherapy.

Huber VJ, Tsujita M, Nakada T.

Mol Aspects Med. 2012 Oct-Dec;33(5-6):691-703. doi: 10.1016/j.mam.2012.01.002. Epub 2012 Jan 24. Review.

PMID:
22293138
44.

Correlates of vaccine protection from influenza and its complications.

McCullers JA, Huber VC.

Hum Vaccin Immunother. 2012 Jan;8(1):34-44. doi: 10.4161/hv.8.1.18214. Epub 2012 Jan 1. Review.

PMID:
22252001
45.

Status of the Southern Carpathian forests in the long-term ecological research network.

Badea O, Bytnerowicz A, Silaghi D, Neagu S, Barbu I, Iacoban C, Iacob C, Guiman G, Preda E, Seceleanu I, Oneata M, Dumitru I, Huber V, Iuncu H, Dinca L, Leca S, Taut I.

Environ Monit Assess. 2012 Dec;184(12):7491-515. doi: 10.1007/s10661-011-2515-7. Epub 2012 Jan 11.

PMID:
22234644
46.

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients.

Filipazzi P, Huber V, Rivoltini L.

Cancer Immunol Immunother. 2012 Feb;61(2):255-63. doi: 10.1007/s00262-011-1161-9. Epub 2011 Nov 27. Review.

PMID:
22120756
47.

To bloom or not to bloom: contrasting responses of cyanobacteria to recent heat waves explained by critical thresholds of abiotic drivers.

Huber V, Wagner C, Gerten D, Adrian R.

Oecologia. 2012 May;169(1):245-56. doi: 10.1007/s00442-011-2186-7. Epub 2011 Nov 26.

PMID:
22120704
48.

Development of a Novel Ligand, [C]TGN-020, for Aquaporin 4 Positron Emission Tomography Imaging.

Nakamura Y, Suzuki Y, Tsujita M, Huber VJ, Yamada K, Nakada T.

ACS Chem Neurosci. 2011 Oct 19;2(10):568-571. Epub 2011 Jun 27.

49.

Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.

Da Riva L, Bozzi F, Mondellini P, Miccichè F, Fumagalli E, Vaghi E, Tarantino E, Huber V, Gronchi A, Tamborini E, Pierotti MA, Pilotti S, Bongarzone I.

J Transl Med. 2011 Sep 23;9:158. doi: 10.1186/1479-5876-9-158.

50.

Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays.

Cwach KT, Sandbulte HR, Klonoski JM, Huber VC.

Influenza Other Respir Viruses. 2012 Mar;6(2):127-35. doi: 10.1111/j.1750-2659.2011.00283.x. Epub 2011 Aug 29.

Supplemental Content

Support Center